Scancell Holdings plc (SCLP) Ord GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
10.25p
10.50p
21.00p
£95.10 million
10.25p
10.00p
7.65p
n/a
0.00p (0.00%) Previous:
0.00p
239,636
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/04/2023 | 30/04/2022 |
---|---|---|
Revenue (£m) | 5.27 | n/a |
Profit before tax (£m) | (14.30) | (6.27) |
Adjusted EPS (p): | (1.50) | (0.56) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Scancell appoints healthcare finance veteran as new CFO
29 August 2023 14:27
-
Scancell to present positive recent findings at oncology summit
2 June 2023 13:18
-
Scancell shares jump on positive cancer vaccine progress
21 February 2023 12:14
-
Scancell Appoints WG as Joint Broker
28 March 2024 13:21
-
First iSCIB1+ patient dosed
26 March 2024 12:22
-
Appointment of Sath Nirmalananthan to the Board
14 March 2024 11:17
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.